Search results
Results from the WOW.Com Content Network
The Journal of Molecular Biology is a biweekly peer-reviewed scientific journal covering all aspects of molecular biology. It was established in 1959 [ 1 ] and is published by Elsevier . The editor-in-chief is Peter Wright ( The Scripps Research Institute ).
* Drugs@FDA includes information about drugs, including biological products, approved for human use in the United States (see FAQ), but does not include information about FDA-approved products regulated by the Center for Biologics Evaluation and Research (for example, vaccines, allergenic products, blood and blood products, plasma derivatives, cellular and gene therapy products).
While these journals still did not receive an impact factor until the next year, they did contribute citations to the calculation of other journals' impact factors. [ 4 ] [ 5 ] In July 2022, Clarivate announced that journals in the ESCI obtain an impact factor effective from JCR Year 2022 first released in June 2023.
Whether you use Microsoft Office Excel, Google Sheets or Apple Numbers, there’s a free spreadsheet for you. These budgeting templates will give you a head start from simple monthly and yearly ...
The impact factor relates to a specific time period; it is possible to calculate it for any desired period. For example, the JCR also includes a five-year impact factor, which is calculated by dividing the number of citations to the journal in a given year by the number of articles published in that journal in the previous five years. [14] [15]
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
The first list was published in 1977 and included 208 medications. [8] [2] [9] The WHO updates the list every two years. [10] There are 306 medications in the 14th list in 2005, [11] 410 in the 19th list in 2015, [10] 433 in the 20th list in 2017, [12] [13] 460 in the 21st list in 2019, [14] [15] [16] and 479 in the 22nd list in 2021.
As of 2023, Annual Review of Medicine is being published as open access, under the Subscribe to Open model. [1] As of 2024, Journal Citation Reports gives the journal a 2023 impact factor of 15.1, ranking it third of 189 titles in the category "Medicine, Research & Experimental". [2]